Wszystko o zwierzętach.
Dołączył: 14 Sty 2011
Przeczytał: 0 tematów
|Wysłany: Pią 4:27, 08 Kwi 2011 Temat postu: cheap jordan 7 Access To Hospital Pharmaceutical M
[link widoczny dla zalogowanych]
London Procurement Programme
3.3 Procurement in Scotland
3.4 Procurement in Wales
3.5 Procurement in Northern Ireland
3.6 Strategic Implications
For more information please contact :
Email: [link widoczny dla zalogowanych]
Collaborative Procurement Hubs
Case Study: Anticancers
NHS Purchasing and Supply Agency
DoH Commercial Directorate
2.3 Health Technology Assessment
NHS Northern Ireland
1.3 NHS Funding
1.4 Pharmaceutical Use
NHS Supply Chain
lic hospitals represent a very important market segment for most biopharmaceutical companies in Europe. They are the often the only market for the increasing numbers of speciality drugs emerging from R&D, with many primary care products also unable to get established for maintenance therapy in the community without hospital recommendation first. Though the processes for achieving hospital usage are very different to the reimbursed GP/community pharmacy sector, they have been poorly documented and often little understood. This justpharmareports publication aims to clarify the situation for the UK, a particularly challenging country with four different public healthcare systems, numerous stakeholders, regular reforms, and rigorous health technology assessment.
Medicines prescribed in English hospitals in 2006 were valued at 2.7 billion. This represented 24% of the English NHS drugs bill (hospital prescribing in London alone accounted for 40% of all prescribing costs in the capital). Even more significantly, the hospital drug bill has been rising at more than twice the rate of GP prescribing costs.
Access to Hospital Pharmaceutical Markets in the UK provides:
Comprehensive and clear information on how medicines for hospital use get selected, purchased, distributed, prescribed, dispensed and paid for.
Separate sections on England, Scotland, Wales and Northern Ireland.
Full coverage of the NHS plus two of the largest private providers.
Explanation of tendering, contracting, contract adjudication and other aspects of procurement for both brands and generics.
Clarification of the complex English funding system, Payment by Results.
Special focus on oncology.
What discounts hospitals expect and why value-added tax is a concern.
Features on risk-sharing schemes and on the boom in homecare services.
NICE, SMC [link widoczny dla zalogowanych], AWMSG [link widoczny dla zalogowanych], the PPRS and much, much more
NHS Bodies Concerned
1.5 Strategic Implications
2. Managed Entry of New Drugs
2.1 Horizon Scanning
Good Practice Guide for Contracting
National Pharmaceutical Supplies Group
Pharmaceutical Market Support Group
Table of Contents :
1. Market Background
1.2 National Health Service
2.4 Strategic Implications
3.1 Product Differentiation
3.2 Procurement in England
Public Procurement Directive
Technology Appraisal Process
Post został pochwalony 0 razy
||Wszystkie czasy w strefie EET (Europa)
Nie możesz pisać nowych tematów
Nie możesz odpowiadać w tematach
Nie możesz zmieniać swoich postów
Nie możesz usuwać swoich postów
Nie możesz głosować w ankietach
fora.pl - załóż własne forum dyskusyjne za darmo
Powered by phpBB © 2001, 2005 phpBB Group